An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients is a research paper published in Science Translational Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 69 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NSERC
Grant: Postgraduate Scholarship
NIDDK NIH HHS
Grant: R01 DK119254
U.S. Department of Defense
Grant: NDSEG
NIDDK
Grant: P30DK116074
Novo Nordisk Fonden
Grant: NNF18OC0030896
Natural Sciences and Engineering Research Council of Canada
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5P30DK116074-04
Stanford Diabetes Research Center
National Institutes of Health
Grant: 3R01DK119254-02S1
Co-Formulations of Amylin Analogues with Insulin Analogues for Treatment of Diabetes
FWCI
9.40
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals